Energizer supports fight against breast cancer
ST. LOUIS Energizer will be the presenting sponsor for this year’s Susan G. Komen for the Cure three-day awareness event, the company announced Tuesday.
Energizer is supporting walkers in a much-needed way – by providing a place to recharge their equipment, bodies and spirit — and stay connected to family and friends at the end of each long day of walking. The Energizer tent at three-day for the Cure camps will feature:
- Laptops to empower walkers to share their experiences and stay connected with family and friends, as well as create awareness for the cause by posting a ribbon on the virtual ribbon tree at Energizer.com/komen
- The Recharge Station, where participants can rent Energizer Energi To Go portable power items such as the EnergiStick and XP 1000 portable cell phone chargers, as well as flashlights, lanterns and battery-operated games
- Complimentary chair massages, generously donated by members of the American Massage Therapy Association, a nonprofit organization dedicated to advancing the art, science and practice of massage therapy
- Time for walkers to connect with the local Keep Going blogger, who will be available to engage with walkers, discuss the three-day for the Cure experience, and share their stories of motivation and perseverance
To kick off this year’s sponsorship for The 2010 Susan G. Komen three-day for the Cure — a series of 15 events across the nation where participants walk 60 miles over the course of three days — Energizer is looking for Keep Going bloggers to train and walk in a Komen three-day for the Cure event and blog about their experience. Details can be found on the brand’s Facebook fan page.
“We are proud to continue our support of Susan G. Komen for the Cure and of walkers across the country as they unite for this important cause,” said Jim Olsen, Energizer VP marketing for North America. “The Energizer Bunny symbolizes the determination and resolve that the walkers are tapping into as they trek 60 miles in just three days, and we hope that they will feel motivated to keep working for a cure. We are excited to share this profound experience more widely this year with our Keep Going bloggers, inspiring a deeper sense of community and connection to the cause.”
Dawn Professional names contest winner at industry event
CINCINNATI Procter & Gamble’s Dawn Professional brand has announced the winner of its “Make Your Restaurant Shine” contest at the National Restaurant Association Show in Chicago.
The Dawn Professional line — which provides comprehensive kitchen cleaning solutions to restaurants around the country — awarded Martha Bralkowski, the owner of Jordan’s Bar and Grill in Ridgway, Pa. The award was presented by chef Spike Mendelsohn on the World Culinary Stage, P&G said.
Mendelsohn presented Bralkowski with a $20,000 check for restaurant improvements. She also will receive a one-on-one expert consultation at her restaurant with Mendelsohn later this year. An experienced restaurateur, he will provide expert advice on how to best use the award, share feedback on Jordan’s menu and discuss how to use social media for success. Tips from this session will be featured at www.DawnCelebrations.com.
“Dawn Professional has always been a trusted partner of the restaurant industry, providing products and resources to help restaurants succeed. ‘Make Your Restaurant Shine’ is a way for us to help one deserving restaurant owner — Ms. Bralkowski — in a very personal way,” said Eric Hetrick, director, P&G Professional. “We hope this $20,000 award will help make Jordan’s Bar & Grill an even bigger part of the Ridgway, Penn., community.”
As the winner of the “Make Your Restaurant Shine” contest, Bralkowski also received a paid trip for four adults to the 2010 National Restaurant Association show now underway in Chicago. Contest applications were received online at www.DawnCelebrations.com through April 12.
FDA grants orphan drug designation for Friedreich’s ataxia treatment
WALTHAM, Mass. The Food and Drug Administration has granted special designation to encourage the development of a drug made by Repligen for treating a rare degenerative disease, Repligen said Monday.
Repligen said the FDA’s Office of Orphan Products Development granted orphan drug designation to the drug RG2833, a treatment for Friedreich’s ataxia. The FDA grants orphan drug designation to treatments for rare diseases and grants incentives such as a seven-year market exclusivity period, compared with the usual five years granted to new drugs.
Friedreich’s ataxia is a genetic illness affecting around 15,000 people worldwide that results from a gene defect causing insufficient production of the protein frataxin, leading to degeneration of nerves controlling muscle movements in the arms and legs and nerve tissue in the spinal cord. Symptoms of the disease typically emerge between the ages of 5 and 15 years and lead to severe disability, incapacitation and loss of life in early adulthood.
“We are very pleased to receive orphan drug designation for our Friedreich’s ataxia program,” Repligen CEO Walter Herlihy said. “RG2833 is the first compound that targets activation of the defective gene responsible for Friedreich’s ataxia. If this approach is successful, it has the potential to significantly impact patients’ lives.”